Pembrolizumab & Olaparib: Pancreatic Cancer Trial Results
Promising New Treatment Approach for Metastatic Pancreatic Cancer Identified In a significant development for patients battling advanced pancreatic cancer, early results from the phase 2 POLAR trial suggest a novel, biomarker-driven treatment strategy is yielding encouraging responses. The approach focuses on identifying patients with metastatic pancreatic cancer who exhibit homologous repair deficiency and possess immune … Read more